Simplex Trading
RLAY icon

Simplex Trading’s Relay Therapeutics RLAY Stock Holding History

Simplex Trading’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$72.6K Sell
7,300
-38,300
-84% -$343K ﹤0.01% 5454
2025
Q4 		$386K Sell
45,600
-3,200
-7% -$22.8K ﹤0.01% 3558
2025
Q3 		$254K Buy
48,800
+48,300
+9,660% +$184K ﹤0.01% 4657
2025
Q2 		$1K Sell
500
-7,100
-93% -$21.1K ﹤0.01% 8409
2025
Q1 		$19K Buy
+7,600
New +$29.8K ﹤0.01% 6625
2024
Q4 		– Sell
-4,200
Closed -$29K – 9451
2024
Q3 		$29K Buy
4,200
+3,900
+1,300% +$29.1K ﹤0.01% 6391
2024
Q2 		$1K Sell
300
-2,900
-91% -$19.8K ﹤0.01% 8553
2024
Q1 		$26K Sell
3,200
-500
-14% -$4.88K ﹤0.01% 6883
2023
Q4 		$40K Buy
3,700
+1,000
+37% +$8.44K ﹤0.01% 6303
2023
Q3 		$22K Sell
2,700
-3,300
-55% -$35.5K ﹤0.01% 6550
2023
Q2 		$75K Buy
+6,000
New +$74.6K ﹤0.01% 5416
2022
Q4 		– Sell
-3,000
Closed -$67K – 10221
2022
Q3 		$67K Sell
3,000
-8,400
-74% -$184K ﹤0.01% 6047
2022
Q2 		$190K Buy
+11,400
New +$244K ﹤0.01% 4678
2022
Q1 		– Sell
-1,300
Closed -$39K – 11239
2021
Q4 		$39K Buy
1,300
+300
+30% +$9.48K ﹤0.01% 7572
2021
Q3 		$37K Hold
1,000
– – ﹤0.01% 7888
2021
Q2 		$36K Buy
1,000
+995
+19,900% +$32.8K ﹤0.01% 8046
2021
Q1 		$17K Buy
+5
New +$217 ﹤0.01% 7591

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Simplex Trading's RLAY Position: Q3 2025 in Review

Simplex Trading sold out of Relay Therapeutics (RLAY) in Q3 2025, closing a stake of 2,984 shares — an estimated $11.4K sold.

Simplex Trading first reported a position in RLAY in Q1 2022 and held it in 12 quarters. The position peaked at $195K in Q4 2024. 199 funds tracked by Wall St. Rank hold RLAY as of Q3 2025.

  • Simplex Trading reported no remaining Relay Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 2,984 Relay Therapeutics shares in Q3 2025, an estimated $11.4K.
  • Simplex Trading first reported a position in Relay Therapeutics in Q1 2022 and held it in 12 quarters.
  • Simplex Trading's Relay Therapeutics position peaked at $195K in Q4 2024.
  • 199 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.